Karen A. Dawes's Insider Trades & SAST Disclosures
Karen A. Dawes's most recent trade in Repligen Corp. was a trade of 2,953 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 14, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Karen A. Dawes.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Jun 2024 | 2,953 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.71 per share. | 14 Jun 2024 | 2,953 | 88,170 (0%) | 0% | 67.7 | 199,948 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,576 | 1,576 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 803 | 88,170 (0%) | 0% | 0 | Common Stock | |
| Barinthus Biotherapeutics ... | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2024 | 19,516 | 19,516 | - | - | Share Option (Right to Buy) | |
| Repligen Corp. | A. Karen Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Feb 2024 | 4,626 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Dawes Karen A. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.07 per share. | 27 Feb 2024 | 4,626 | 88,367 (0%) | 0% | 42.1 | 194,616 | Common Stock |
| Repligen Corp. | Dawes Karen A. | Director | Sale of securities on an exchange or to another person at price $ 193.35 per share. | 27 Feb 2024 | 1,000 | 87,367 (0%) | 0% | 193.4 | 193,350 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.12 per share. | 29 Aug 2023 | 7,392 | 84,591 (0%) | 0% | 18.1 | 133,943 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Aug 2023 | 7,392 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 171.38 per share. | 29 Aug 2023 | 850 | 83,741 (0%) | 0% | 171.4 | 145,673 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 1,730 | 1,730 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 798 | 77,199 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 227.17 per share. | 09 Sep 2022 | 775 | 76,401 (0%) | 0% | 227.2 | 176,057 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 1,565 | 1,565 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 644 | 77,176 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 150.19 per share. | 25 May 2022 | 7,677 | 80,994 (0%) | 0% | 150.2 | 1,153,009 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 149.18 per share. | 25 May 2022 | 2,576 | 88,671 (0%) | 0% | 149.2 | 384,288 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 152.14 per share. | 25 May 2022 | 1,875 | 77,274 (0%) | 0% | 152.1 | 285,263 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 151.14 per share. | 25 May 2022 | 1,845 | 79,149 (0%) | 0% | 151.1 | 278,853 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 152.84 per share. | 25 May 2022 | 742 | 76,532 (0%) | 0% | 152.8 | 113,407 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2021 | 4,783 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.12 per share. | 10 Nov 2021 | 4,783 | 96,030 (0%) | 0% | 26.1 | 124,932 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 263.23 per share. | 10 Nov 2021 | 1,119 | 93,175 (0%) | 0% | 263.2 | 294,554 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 262.28 per share. | 10 Nov 2021 | 1,038 | 94,294 (0%) | 0% | 262.3 | 272,247 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 265.27 per share. | 10 Nov 2021 | 488 | 92,351 (0%) | 0% | 265.3 | 129,452 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 266.72 per share. | 10 Nov 2021 | 486 | 91,865 (0%) | 0% | 266.7 | 129,626 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 259.75 per share. | 10 Nov 2021 | 462 | 95,568 (0%) | 0% | 259.8 | 120,005 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 267.75 per share. | 10 Nov 2021 | 349 | 91,516 (0%) | 0% | 267.8 | 93,445 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 264.21 per share. | 10 Nov 2021 | 336 | 92,839 (0%) | 0% | 264.2 | 88,775 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 269.94 per share. | 10 Nov 2021 | 255 | 91,261 (0%) | 0% | 269.9 | 68,835 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 261.10 per share. | 10 Nov 2021 | 236 | 95,332 (0%) | 0% | 261.1 | 61,620 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 271.29 per share. | 10 Nov 2021 | 14 | 91,247 (0%) | 0% | 271.3 | 3,798 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 305.91 per share. | 02 Nov 2021 | 700 | 91,530 (0%) | 0% | 305.9 | 214,137 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 303.48 per share. | 02 Nov 2021 | 532 | 92,354 (0%) | 0% | 303.5 | 161,451 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 301.97 per share. | 02 Nov 2021 | 446 | 92,886 (0%) | 0% | 302.0 | 134,679 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 306.49 per share. | 02 Nov 2021 | 283 | 91,247 (0%) | 0% | 306.5 | 86,737 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 301.20 per share. | 02 Nov 2021 | 251 | 93,332 (0%) | 0% | 301.2 | 75,601 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 304.23 per share. | 02 Nov 2021 | 124 | 92,230 (0%) | 0% | 304.2 | 37,725 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 299.02 per share. | 02 Nov 2021 | 64 | 93,583 (0%) | 0% | 299.0 | 19,137 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 295.02 per share. | 14 Sep 2021 | 108 | 93,674 (0%) | 0% | 295.0 | 31,862 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 294.06 per share. | 14 Sep 2021 | 101 | 93,782 (0%) | 0% | 294.1 | 29,700 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 295.81 per share. | 14 Sep 2021 | 27 | 93,647 (0%) | 0% | 295.8 | 7,987 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 292.36 per share. | 14 Sep 2021 | 25 | 93,883 (0%) | 0% | 292.4 | 7,309 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 290.00 per share. | 14 Sep 2021 | 13 | 93,908 (0%) | 0% | 290 | 3,770 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.76 per share. | 01 Sep 2021 | 3,459 | 97,380 (0%) | 0% | 38.8 | 134,071 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 3,459 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 284.64 per share. | 01 Sep 2021 | 1,107 | 94,772 (0%) | 0% | 284.6 | 315,096 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 285.44 per share. | 01 Sep 2021 | 851 | 93,921 (0%) | 0% | 285.4 | 242,909 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 283.56 per share. | 01 Sep 2021 | 661 | 95,879 (0%) | 0% | 283.6 | 187,433 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 282.53 per share. | 01 Sep 2021 | 405 | 96,540 (0%) | 0% | 282.5 | 114,425 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 280.27 per share. | 01 Sep 2021 | 239 | 97,141 (0%) | 0% | 280.3 | 66,985 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 281.68 per share. | 01 Sep 2021 | 196 | 96,945 (0%) | 0% | 281.7 | 55,209 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 254.09 per share. | 17 Aug 2021 | 8,580 | 97,788 (0%) | 0% | 254.1 | 2,180,092 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 253.34 per share. | 17 Aug 2021 | 4,665 | 106,368 (0%) | 0% | 253.3 | 1,181,831 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 255.07 per share. | 17 Aug 2021 | 2,231 | 95,557 (0%) | 0% | 255.1 | 569,061 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 251.15 per share. | 17 Aug 2021 | 924 | 111,953 (0%) | 0% | 251.2 | 232,063 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 251.92 per share. | 17 Aug 2021 | 920 | 111,033 (0%) | 0% | 251.9 | 231,766 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 258.91 per share. | 17 Aug 2021 | 634 | 94,427 (0%) | 0% | 258.9 | 164,149 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 259.93 per share. | 17 Aug 2021 | 388 | 94,039 (0%) | 0% | 259.9 | 100,853 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 257.66 per share. | 17 Aug 2021 | 302 | 95,061 (0%) | 0% | 257.7 | 77,813 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 256.43 per share. | 17 Aug 2021 | 194 | 95,363 (0%) | 0% | 256.4 | 49,747 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 260.91 per share. | 17 Aug 2021 | 78 | 93,961 (0%) | 0% | 260.9 | 20,351 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 262.30 per share. | 17 Aug 2021 | 40 | 93,921 (0%) | 0% | 262.3 | 10,492 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 202.29 per share. | 20 Jul 2021 | 2,877 | 113,491 (0%) | 0% | 202.3 | 581,988 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 201.37 per share. | 20 Jul 2021 | 806 | 116,368 (0%) | 0% | 201.4 | 162,304 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 203.11 per share. | 20 Jul 2021 | 614 | 112,877 (0%) | 0% | 203.1 | 124,710 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 200.01 per share. | 20 Jul 2021 | 288 | 117,174 (0%) | 0% | 200.0 | 57,603 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 41.19 per share. | 13 Jul 2021 | 2,929 | 118,982 (0%) | 0% | 41.2 | 120,646 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 2,929 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 202.29 per share. | 13 Jul 2021 | 630 | 117,911 (0%) | 0% | 202.3 | 127,443 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 203.09 per share. | 13 Jul 2021 | 444 | 117,467 (0%) | 0% | 203.1 | 90,172 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 201.27 per share. | 13 Jul 2021 | 441 | 118,541 (0%) | 0% | 201.3 | 88,760 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 204.00 per share. | 13 Jul 2021 | 5 | 117,462 (0%) | 0% | 204 | 1,020 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 1,522 | 1,522 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 604 | 116,053 (0%) | 0% | 0 | Common Stock | |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.22 per share. | 11 May 2021 | 15,000 | 115,734 (0%) | 0% | 3.2 | 48,300 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 176.85 per share. | 11 May 2021 | 285 | 115,449 (0%) | 0% | 176.8 | 50,402 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 115.76 per share. | 18 Jun 2020 | 8,217 | 103,302 (0%) | 0% | 115.8 | 951,200 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 114.49 per share. | 18 Jun 2020 | 5,243 | 111,519 (0%) | 0% | 114.5 | 600,271 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 113.58 per share. | 18 Jun 2020 | 2,677 | 116,762 (0%) | 0% | 113.6 | 304,054 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 116.56 per share. | 18 Jun 2020 | 2,568 | 100,734 (0%) | 0% | 116.6 | 299,326 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 139.40 per share. | 20 May 2020 | 282 | 119,621 (0%) | 0% | 139.4 | 39,311 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 140.29 per share. | 20 May 2020 | 182 | 119,439 (0%) | 0% | 140.3 | 25,533 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 136.98 per share. | 20 May 2020 | 43 | 119,903 (0%) | 0% | 137.0 | 5,890 | Common Stock |
| Repligen Corp. | Karen A. Dawes | Director | Sale of securities on an exchange or to another person at price $ 135.90 per share. | 20 May 2020 | 10 | 119,946 (0%) | 0% | 135.9 | 1,359 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges